The Pandemic Broke the Flu
This winter has been an extraordinarily quiet flu season. Scientists aren’t sure the silence will last, according to a report in The Atlantic.
Read MorePosted by Laurie Bonner | Feb 5, 2021 | Covid 19, Flu & Respiratory Infections |
This winter has been an extraordinarily quiet flu season. Scientists aren’t sure the silence will last, according to a report in The Atlantic.
Read MorePosted by Laurie Bonner | Feb 4, 2021 | Covid 19, Molecular Diagnostics |
T2 Biosystems’ panel can detect multiple variants of the SARS-CoV-2 virus, including those most recently identified in the United Kingdom, South Africa, and the United States.
Read MorePosted by Laurie Bonner | Feb 3, 2021 | Company News, Covid 19, Point-of-Care |
With BARDA funding, Visby will advance a next-generation device to detect flu and/or covid-19 in one hand-held rapid PCR test for use at the point-of-need and eventually in consumers’ homes as an over-the-counter test.
Read MorePosted by Laurie Bonner | Feb 3, 2021 | Company News, Covid 19, Molecular Diagnostics |
A $5.5M award from the National Institutes of Health plus an additional grant from JobsOhio will help Meridian expand production of its Revogene test kits in its Quebec City facility and build a new state-of-the-art, two-line production facility near its corporate headquarters in Ohio.
Read MorePosted by Laurie Bonner | Feb 1, 2021 | Covid 19, Miscellaneous |
WHO’s yearly essential diagnostics list offers recommended in vitro diagnostics that should be available at point-of-care and in laboratories in all countries to increase timely and life-saving diagnoses.
Read More